A small study has found that the experimental drug donanemab may slow cognitive decline in Alzheimer's patients. It joins others that show promise.
Show MoreBrowse more
View all ArticlesAdjacent discoveries
Contribute to FoundryBase
Sign in to suggest resources and start building your own collection.